Search

Smith & Nephew PLC

Lezárt

1,225 -0.65

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1223

Maximum

1225.5

Fő mutatók

By Trading Economics

Bevétel

296M

Értékesítés

3B

P/E

Szektor átlag

28.81

23.145

Egy részvényre jutó nyereség

0.429

Osztalékhozam

3.08

Profit margin

9.895

Munkavállalók

17,000

EBITDA

723M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+19.58% upside

Osztalékok

By Dow Jones

Osztalékhozam

Szektor átlag

3.08%

4.30%

Következő eredményjelentés

2026. márc. 2.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

1.3B

10B

Előző nyitás

1225.65

Előző zárás

1225

Smith & Nephew PLC Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. jan. 23. 18:41 UTC

Eredményjelentés

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

2026. jan. 23. 22:30 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2026. jan. 23. 22:30 UTC

Piaci beszéd

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

2026. jan. 23. 22:03 UTC

Eredményjelentés

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

2026. jan. 23. 21:52 UTC

Eredményjelentés
Felvásárlások, összeolvadások, átvételek

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

2026. jan. 23. 21:50 UTC

Piaci beszéd
Eredményjelentés

Tech, Media & Telecom Roundup: Market Talk

2026. jan. 23. 21:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2026. jan. 23. 21:50 UTC

Piaci beszéd

Financial Services Roundup: Market Talk

2026. jan. 23. 21:50 UTC

Piaci beszéd

Auto & Transport Roundup: Market Talk

2026. jan. 23. 21:39 UTC

Eredményjelentés

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

2026. jan. 23. 21:15 UTC

Felvásárlások, összeolvadások, átvételek

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

2026. jan. 23. 21:12 UTC

Eredményjelentés

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

2026. jan. 23. 20:31 UTC

Eredményjelentés

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

2026. jan. 23. 20:12 UTC

Piaci beszéd

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

2026. jan. 23. 20:07 UTC

Piaci beszéd

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

2026. jan. 23. 19:36 UTC

Piaci beszéd

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

2026. jan. 23. 19:30 UTC

Piaci beszéd
Eredményjelentés

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

2026. jan. 23. 19:18 UTC

Piaci beszéd

Gold and Silver Step Up to More Records -- Market Talk

2026. jan. 23. 19:15 UTC

Eredményjelentés

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

2026. jan. 23. 18:53 UTC

Piaci beszéd

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

2026. jan. 23. 18:21 UTC

Eredményjelentés

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

2026. jan. 23. 18:19 UTC

Piaci beszéd

Intel Seen as Increasingly Confident on Demand -- Market Talk

2026. jan. 23. 17:59 UTC

Eredményjelentés

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

2026. jan. 23. 17:57 UTC

Piaci beszéd

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

2026. jan. 23. 17:57 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2026. jan. 23. 17:34 UTC

Piaci beszéd
Eredményjelentés

Intel's Supply Challenges Seen Benefiting AMD -- Market Talk

2026. jan. 23. 17:20 UTC

Piaci beszéd

Financial Services Roundup: Market Talk

2026. jan. 23. 17:20 UTC

Piaci beszéd

Auto & Transport Roundup: Market Talk

2026. jan. 23. 17:20 UTC

Piaci beszéd

Health Care Roundup: Market Talk

2026. jan. 23. 17:13 UTC

Piaci beszéd
Eredményjelentés

Global Equities Roundup: Market Talk

Smith & Nephew PLC Előrejelzés

Célár

By TipRanks

19.58% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 1,465.5 GBX  19.58%

Magas 1,650 GBX

Alacsony 1,290 GBX

8 Wall Street elemző 12 hónapos célárain alapulva a(z)Smith & Nephew PLC termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

8 ratings

5

Vétel

3

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat